Elicera Therapeutics AB (ELIC)
Market Closed
15 Oct, 03:25 PM
XSTO XSTO Primary kr
2. 99
-0.1
-3.2362%
kr
263.06M Market Cap
- P/E Ratio
- Div Yield
362,067 Volume
0 Eps
kr 3.09
Previous Close Want to track ELIC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Elicera Therapeutics AB (ELIC) Statistics
Valuation metrics
Market Cap 263.06M
Enterprise value 125.73M
Trailing P/E (ttm) -7.79
Forward P/E -
PEG ratio 2.53
Price/Sales (ttm) -1,245.18
Price/Book (mrq) 2.61
Enterprise Value/Revenue -851.52
Enterprise Value/EBITDA -6.97
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 141.18K
Average volume (90 days) 331.41K
Price summary
52-Week low 2.93
52-Week high 8.43
Beta -
50-Day moving average 2.77
200-Day moving average 3.15
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 121.79%
Operating margin 124.65%
Operational effectiveness
Return on assets -0.3%
Return on equity -0.56%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -0
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.34
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.09
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 17.81%
Book value per share (mrq) 1.05
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
